COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis

Abstract

Dermatomyositis patients without comorbities have reasonable COVID-19 outcomes including mortality and hospitalisation. Black race, male gender, ILD, DMARDS and glucocorticoid users, are associated with poor outcomes.